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Background: Doxorubicin (DOXO) is an effective chemotherapeutic drug used in the treatment of various cancers. Unfortunately, cardiotoxicity 
has limited its clinical applications. Cell therapy is a promising option to treat cardiotoxicity. Therefore, we examined for the first time the effects 
of transplanted induced pluripotent stem (iPS) cells in combined model of DOXO induced cardiotoxicity followed by myocardial infarction (MI) on 
apoptosis, apoptotic pathway, cardiac and vascular fibrosis and cardiac function.
Methods: C57BL/6 mice were divided into five groups: Sham, DOXO-MI, DOXO-MI+cell culture (CC) media, DOXO-MI+ES cells (pluripotent cells 
as a control), and DOXO -MI+iPS cells. Mice were injected 3 times every other day with cumulative dose of DOXO, 12 mg/kg. Two weeks after last 
injection, MI was induced by coronary artery ligation. Following ligation, 5 x 104 ES or iPS cells or CC medium were delivered into the peri-infarct 
region. At day 14 post-MI, echocardiography was performed, mice were sacrificed, and hearts were harvested for further analyses.
Results: Our data reveals apoptosis was significantly inhibited in iPS cell transplanted hearts compared with DOXO-MI, DOXO-MI+CC (Sham: 
0.219%±0.0435; DOXO-MI: 0.893%±0.091; DOXO-MI-CC: 0.958%±0.161; DOXO-MI-iPS: 0.325%±0.0532; p <0.05; n=7-9). Furthermore, our 
data suggest a significant increase in pAkt, a cell survival protein, and a decrease in levels of PTEN, a negative regulator of Akt pathway in hearts 
transplanted with iPS cells. Additionally, a significant (p<0.05; n=5-8) decrease in vascular and interstitial fibrosis along with improved heart 
function (Sham: 51.7%±2.829, DOXO-MI: 36.786%±1.548, DOXO-MI-CC: 38.2%±2.237, DOXO-MI-iPS: 45.917%±1.533; p <0.05 vs DOXO-MI and 
DOXO-MI-CC, n=6-8) was observed in iPS cell transplanted group. Moreover, data generated with ES cell group has similar findings as observed in 
iPS cells.
Conclusion: Our data suggests that transplanted iPS cells inhibit apoptosis mediated by Akt/PTEN pathway, attenuate adverse cardiac remodeling 
along with improved cardiac function in DOXO induced cardiotoxicity followed by MI.
